SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kelly Jennifer A.) "

Sökning: WFRF:(Kelly Jennifer A.)

  • Resultat 61-70 av 85
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  •  
62.
  • White, Paul J, et al. (författare)
  • Identifying the core concepts of pharmacology education: A global initiative.
  • 2022
  • Ingår i: British journal of pharmacology. - : Wiley. - 0007-1188 .- 1476-5381. ; 180:9, s. 1197-1209
  • Tidskriftsartikel (refereegranskat)abstract
    • In recent decades, a focus on the most critical and fundamental concepts has proven highly advantageous to students and educators in many science disciplines. Pharmacology, unlike microbiology, biochemistry, or physiology, lacks a consensus list of such core concepts.We sought to develop a research-based, globally relevant list of core concepts that all students completing a foundational pharmacology course should master. This two-part project consisted of exploratory and refinement phases. The exploratory phase involved empirical data mining of the introductory sections of five key textbooks, in parallel with an online survey of over 200 pharmacology educators from 17 countries across six continents. The refinement phase involved three Delphi rounds involving 24 experts from 15 countries across six continents.The exploratory phase resulted in a consolidated list of 74 candidate core concepts. In the refinement phase, the expert group produced a consensus list of 25 core concepts of pharmacology.This list will allow pharmacology educators everywhere to focus their efforts on the conceptual knowledge perceived to matter most by experts within the discipline. Next steps for this project include defining and unpacking each core concept and developing resources to help pharmacology educators globally teach and assess these concepts within their educational contexts.
  •  
63.
  • Aho, Kelly S., et al. (författare)
  • Distinct concentration-discharge dynamics in temperate streams and rivers : CO2 exhibits chemostasis while CH4 exhibits source limitation due to temperature control
  • 2021
  • Ingår i: Limnology and Oceanography. - : John Wiley & Sons. - 0024-3590 .- 1939-5590. ; 66:10, s. 3656-3668
  • Tidskriftsartikel (refereegranskat)abstract
    • Streams and rivers are significant sources of carbon dioxide (CO2) and methane (CH4) to the atmosphere. However, the magnitudes of these fluxes are uncertain, in part, because dissolved greenhouse gases (GHGs) can exhibit high spatiotemporal variability. Concentration-discharge (C-Q) relationships are commonly used to describe temporal variability stemming from hydrologic controls on solute production and transport. This study assesses how the partial pressures of two GHGs—pCO2 and pCH4—vary across hydrologic conditions over 4 yr in eight nested streams and rivers, at both annual and seasonal timescales. Overall, the range of pCO2 was constrained, ranging from undersaturated to nine times oversaturated, while pCH4 was highly variable, ranging from 3 to 500 times oversaturated. We show that pCO2 exhibited chemostatic behavior (i.e., no change with Q), in part, due to carbonate buffering and seasonally specific storm responses. In contrast, we show that pCH4 generally exhibited source limitation (i.e., a negative relationship with Q), which we attribute to temperature-mediated production. However, pCH4 exhibited chemostasis in a wetland-draining stream, likely due to hydrologic connection to the CH4-rich wetland. These findings have implications for CO2 and CH4 fluxes, which are controlled by concentrations and gas transfer velocities. At high Q, enhanced gas transfer velocity acts on a relatively constant CO2 stock but on a diminishing CH4 stock. In other words, CO2 fluxes increase with Q, while CH4 fluxes are modulated by the divergent Q dynamics of gas transfer velocity and concentration.
  •  
64.
  • Bolton, Kelly L., et al. (författare)
  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
  • 2012
  • Ingår i: JAMA: The Journal of the American Medical Association. - : American Medical Association (AMA). - 1538-3598. ; 307:4, s. 382-390
  • Tidskriftsartikel (refereegranskat)abstract
    • Context Approximately 10% of women with invasive epithelial ovarian cancer (EOC) carry deleterious germline mutations in BRCA1 or BRCA2. A recent article suggested that BRCA2-related EOC was associated with an improved prognosis, but the effect of BRCA1 remains unclear. Objective To characterize the survival of BRCA carriers with EOC compared with noncarriers and to determine whether BRCA1 and BRCA2 carriers show similar survival patterns. Design, Setting, and Participants A pooled analysis of 26 observational studies on the survival of women with ovarian cancer, which included data from 1213 EOC cases with pathogenic germline mutations in BRCA1 (n=909) or BRCA2 (n=304) and from 2666 noncarriers recruited and followed up at variable times between 1987 and 2010 (the median year of diagnosis was 1998). Main Outcome Measure Five-year overall mortality. Results The 5-year overall survival was 36% (95% CI, 34%-38%) for noncarriers, 44% (95% CI, 40%-48%) for BRCA1 carriers, and 52% (95% CI, 46%-58%) for BRCA2 carriers. After adjusting for study and year of diagnosis, BRCA1 and BRCA2 mutation carriers showed a more favorable survival than noncarriers (for BRCA1: hazard ratio [HR], 0.78; 95% CI, 0.68-0.89; P<.001; and for BRCA2: HR, 0.61; 95% CI, 0.50-0.76; P<.001). These survival differences remained after additional adjustment for stage, grade, histology, and age at diagnosis (for BRCA1: HR, 0.73; 95% CI, 0.64-0.84; P<.001; and for BRCA2: HR, 0.49; 95% CI, 0.39-0.61; P<.001). The BRCA1 HR estimate was significantly different from the HR estimated in the adjusted model (P for heterogeneity=.003). Conclusion Among patients with invasive EOC, having a germline mutation in BRCA1 or BRCA2 was associated with improved 5-year overall survival. BRCA2 carriers had the best prognosis. JAMA. 2012;307(4):382-390
  •  
65.
  • Couthouis, Julien, et al. (författare)
  • A yeast functional screen predicts new candidate ALS disease genes
  • 2011
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - : Proceedings of the National Academy of Sciences. - 0027-8424 .- 1091-6490. ; 108:52, s. 20881-20890
  • Tidskriftsartikel (refereegranskat)abstract
    • Amyotrophic lateral sclerosis (ALS) is a devastating and universally fatal neurodegenerative disease. Mutations in two related RNA-binding proteins, TDP-43 and FUS, that harbor prion-like domains, cause some forms of ALS. There are at least 213 human proteins harboring RNA recognition motifs, including FUS and TDP-43, raising the possibility that additional RNA-binding proteins might contribute to ALS pathogenesis. We performed a systematic survey of these proteins to find additional candidates similar to TDP-43 and FUS, followed by bioinformatics to predict prion-like domains in a subset of them. We sequenced one of the segenes, TAF15, in patients with ALS and identified missense variants, which were absent in a large number of healthy controls. These disease-associated variants of TAF15 caused formation of cytoplasmic foci when expressed in primary cultures of spinal cord neurons. Very similar to TDP-43 and FUS, TAF15 aggregated in vitro and conferred neurodegeneration in Drosophila, with the ALS-linked variants having amore severe effect than wild type. Immunohistochemistry of postmortem spinal cord tissue revealed mislocalization of TAF15 in motor neurons of patients with ALS. We propose that aggregation-prone RNA-binding proteins might contribute very broadly to ALS pathogenesis and the genes identified in our yeast functional screen, coupled with prion-like domain prediction analysis, now provide a powerful resource to facilitate ALS disease gene discovery.
  •  
66.
  • Gaziano, Liam, et al. (författare)
  • Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
  • 2021
  • Ingår i: Nature Medicine. - : Springer Nature. - 1078-8956 .- 1546-170X. ; 27:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Large-scale Mendelian randomization and colocalization analyses using gene expression and soluble protein data for 1,263 actionable druggable genes, which encode protein targets for approved drugs or drugs in clinical development, identify IFNAR2 and ACE2 as the most promising therapeutic targets for early management of COVID-19. Drug repurposing provides a rapid approach to meet the urgent need for therapeutics to address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted Mendelian randomization analyses, deriving genetic instruments based on transcriptomic and proteomic data for 1,263 actionable proteins that are targeted by approved drugs or in clinical phase of drug development. Using summary statistics from the Host Genetics Initiative and the Million Veteran Program, we studied 7,554 patients hospitalized with COVID-19 and >1 million controls. We found significant Mendelian randomization results for three proteins (ACE2, P = 1.6 x 10(-6); IFNAR2, P = 9.8 x 10(-11) and IL-10RB, P = 2.3 x 10(-14)) using cis-expression quantitative trait loci genetic instruments that also had strong evidence for colocalization with COVID-19 hospitalization. To disentangle the shared expression quantitative trait loci signal for IL10RB and IFNAR2, we conducted phenome-wide association scans and pathway enrichment analysis, which suggested that IFNAR2 is more likely to play a role in COVID-19 hospitalization. Our findings prioritize trials of drugs targeting IFNAR2 and ACE2 for early management of COVID-19.
  •  
67.
  •  
68.
  • Harris, Valerie M., et al. (författare)
  • Klinefelters syndrome (47,XXY) is in excess among men with Sjogrens syndrome
  • 2016
  • Ingår i: Clinical Immunology. - : ACADEMIC PRESS INC ELSEVIER SCIENCE. - 1521-6616 .- 1521-7035. ; 168, s. 25-29
  • Tidskriftsartikel (refereegranskat)abstract
    • Primary Sjogrens syndrome (pSS) has a strong female bias. We evaluated an X chromosome dose effect by analyzing 47,XXY (Klinefelters syndrome, 1 in 500 live male births) among subjects with pSS. 47,XXY was determined by examination of fluorescence intensity of single nucleotide polymorphisms from the X and Y chromosomes. Among 136 pSS men there were 4 with 47,XXY. This was significantly different from healthy controls (1 of 1254 had 47)0(Y, p = 0.0012 by Fishers exact test) as well men with rheumatoid arthritis (0 of 363 with 47,XXY), but not different compared to men with systemic lupus erythematosus (SLE) (4 of 136 versus 8 of 306, Fishers exact test p = NS). These results are consistent with the hypothesis that the number of X chromosomes is critical for the female bias of pSS, a property that may be shared with SLE but not RA. Published by Elsevier Inc.
  •  
69.
  • Namjou, Bahram, et al. (författare)
  • High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups
  • 2009
  • Ingår i: Arthritis and Rheumatism. - : Wiley. - 0004-3591 .- 1529-0131. ; 60:4, s. 1085-1095
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disorder, with complex etiology and a strong genetic component. Recently, gene products involved in the interferon pathway have been under intense investigation in terms of the pathogenesis of SLE. STAT-1 and STAT-4 are transcription factors that play key roles in the interferon and Th1 signaling pathways, making them attractive candidates for involvement in SLE susceptibility. METHODS: Fifty-six single-nucleotide polymorphisms (SNPs) across STAT1 and STAT4 on chromosome 2 were genotyped using the Illumina platform, as part of an extensive association study in a large collection of 9,923 lupus patients and control subjects from different racial groups. DNA samples were obtained from the peripheral blood of patients with SLE and control subjects. Principal components analyses and population-based case-control association analyses were performed, and the P values, false discovery rate q values, and odds ratios with 95% confidence intervals were calculated. RESULTS: We observed strong genetic associations with SLE and multiple SNPs located within STAT4 in different ethnic groups (Fisher's combined P = 7.02 x 10(-25)). In addition to strongly confirming the previously reported association in the third intronic region of this gene, we identified additional haplotypic association across STAT4 and, in particular, a common risk haplotype that is found in multiple racial groups. In contrast, only a relatively weak suggestive association was observed with STAT1, probably due to its proximity to STAT4. CONCLUSION: Our findings indicate that STAT4 is likely to be a crucial component in SLE pathogenesis in multiple racial groups. Knowledge of the functional effects of this association, when they are revealed, might improve our understanding of the disease and provide new therapeutic targets.
  •  
70.
  • Nath, Swapan K., et al. (författare)
  • A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus
  • 2008
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 40:2, s. 152-154
  • Tidskriftsartikel (refereegranskat)abstract
    • We identified and replicated an association between ITGAM (CD11b) at 16p11.2 and risk of systemic lupus erythematosus (SLE) in 3,818 individuals of European descent. The strongest association was at a nonsynonymous SNP, rs1143679 (P = 1.7 x 10(-17), odds ratio = 1.78). We further replicated this association in two independent samples of individuals of African descent (P = 0.0002 and 0.003; overall meta-analysis P = 6.9 x 10(-22)). The genetic association between ITGAM and SLE implicates the alpha(M)beta2-integrin adhesion pathway in disease development.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 61-70 av 85
Typ av publikation
tidskriftsartikel (83)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (82)
övrigt vetenskapligt/konstnärligt (3)
Författare/redaktör
Kelly, Jennifer A. (26)
Harley, John B. (26)
Alarcón-Riquelme, Ma ... (20)
Kaufman, Kenneth M. (20)
James, Judith A. (19)
Gaffney, Patrick M. (18)
visa fler...
Vyse, Timothy J. (17)
Guthridge, Joel M. (16)
Gilkeson, Gary S. (15)
Merrill, Joan T. (15)
Kimberly, Robert P. (14)
Langefeld, Carl D. (14)
Anaya, Juan-Manuel (13)
Witte, Torsten (12)
Lessard, Christopher ... (12)
Scofield, R. Hal (11)
Moser, Kathy L. (11)
Loos, Ruth J F (11)
Nordmark, Gunnel (10)
Wahren-Herlenius, Ma ... (10)
Reveille, John D. (10)
Edberg, Jeffrey C. (10)
Freedman, Barry I. (10)
Jacob, Chaim O. (10)
Kamen, Diane L. (10)
Tsao, Betty P. (10)
Magnusson, Patrik K ... (10)
Boomsma, Dorret I. (10)
Jonsson, Roland (10)
Gudnason, Vilmundur (10)
Mariette, Xavier (10)
Ng, Wan-Fai (10)
Rasmussen, Astrid (10)
Rischmueller, Mauree ... (10)
Bae, Sang-Cheol (9)
Ramsey-Goldman, Rosa ... (9)
Criswell, Lindsey A. (9)
Eriksson, Per (9)
van Duijn, Cornelia ... (9)
Pedersen, Nancy L (9)
Boehnke, Michael (9)
Rotter, Jerome I. (9)
Willemsen, Gonneke (9)
Omdal, Roald (9)
Harris, Tamara B (9)
Psaty, Bruce M (9)
Elliott, Paul (9)
Cunninghame Graham, ... (9)
Radfar, Lida (9)
Stone, Donald U. (9)
visa färre...
Lärosäte
Uppsala universitet (41)
Karolinska Institutet (35)
Lunds universitet (21)
Umeå universitet (20)
Göteborgs universitet (11)
Stockholms universitet (9)
visa fler...
Linköpings universitet (9)
Örebro universitet (3)
Jönköping University (3)
Malmö universitet (3)
Mittuniversitetet (3)
Högskolan i Skövde (3)
Sveriges Lantbruksuniversitet (3)
Chalmers tekniska högskola (2)
Högskolan Dalarna (2)
Kungliga Tekniska Högskolan (1)
Högskolan i Halmstad (1)
Södertörns högskola (1)
Karlstads universitet (1)
visa färre...
Språk
Engelska (85)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (48)
Naturvetenskap (26)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy